Intrinsiqq
Stryker Corporation logo

Stryker Corporation Insider Trading

SYK

⊜ Compare
Last 12 months

Insiders bought 23K and sold $586M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Ronda E Stryker sold $185M on Nov 6, 2025 outside a plan.

Net open-market
−$586M
1 buy · 11 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
1 / 8
executives and directors
Last open-market buy
Sep 2026
Sep 2, 2026

Get an email when SYK's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 2
    Mary K Brainerd
    Director · bought 113 at avg $200.74
    23K
    1.4% of stake
  • Aug 21No plan
    Dylan Bram Crotty
    Group President · sold 441 at $328.61
    145K
    3.1% of stake
  • Aug 18 – 19No plan
    Ronda E Stryker
    Director · sold 350,000 at avg $336.50
    $118M
    2.4% of stake
  • Aug 18No plan
    Debra King
    See Remarks · sold 826 at $336.30
    278K
    12% of stake
  • May 2810b5-1 plan
    Robert S Fletcher
    VP, Chief Legal Officer · sold 4,544 at avg $306.87
    $1.39M
    30% of stake
  • May 26No plan
    Ronda E Stryker
    Director · sold 310,000 at avg $312.23
    $96.8M
    2.0% of stake
  • May 11No plan
    M Kathryn Fink
    VP, Chief HR Officer · sold 8,720 at avg $283.69
    $2.47M
    39% of stake
  • Feb 4 – 5No plan
    Ronda E Stryker
    Director · sold 500,000 at avg $363.44
    $182M
    3.1% of stake
  • Feb 2No plan
    James Andrew Pierce
    Group President · sold 475 at $368.87
    175K
    0.6% of stake
  • Nov 20, 2025No plan
    Preston Wendell Wells
    VP, Chief Financial Officer · sold 165 at $365.88
    60K
    2.3% of stake
  • Nov 14, 2025No plan
    William E Berry Jr
    VP, Chief Accounting Officer · sold 1,953 at $365.49
    714K
    36% of stake
  • Nov 5, 2025 – Nov 6, 2025No plan
    Ronda E Stryker
    Director · sold 520,000 at avg $355.01
    $185M
    3.1% of stake
  • Aug 25, 2025No plan
    Viju Menon
    Group President · sold 500 at $390.61
    195K
    3.8% of stake
  • Aug 20, 2025No plan
    Robert S Fletcher
    VP, Chief Legal Officer · sold 1,785 at $393.07
    702K
    14% of stake
  • Aug 6, 2025No plan
    Ronda E Stryker
    Director · sold 200,000 at avg $376.45
    $75.3M
    1.2% of stake
  • May 12, 2025No plan
    William E Berry Jr
    VP, Chief Accounting Officer · sold 1,241 at $388.56
    482K
    26% of stake
  • May 6, 2025No plan
    Ronda E Stryker
    Director · sold 200,000 at avg $376.96
    $75.4M
    1.2% of stake
  • Feb 18, 2025No plan
    Allan C. Golston
    Director · sold 2,458 at $383.07
    942K
    14% of stake
  • Jan 31, 2025No plan
    Ronda E Stryker
    Director · sold 236,000 at avg $392.75
    $92.7M
    6.1% of stake
  • Nov 15, 2024No plan
    Spencer S Stiles
    Group President · sold 514 at $391.16
    201K
    1.0% of stake
  • Nov 7, 2024No plan
    Kevin Lobo
    Chair and CEO · sold 57,313 at avg $368.70
    $21.1M
    36% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SYK, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with SYK

CompareIntrinsic value
MMM3M Company
$193.99+9.57%46
MDLNMedline Inc.
$40.35+18.36%31
BDXBecton, Dickinson and Company
$209.19+5.56%52
BSXBoston Scientific Corporation
$45.82+5.33%80
BAXBaxter International Inc.
$26.50+3.96%32
SOLVSolventum Corporation
$89.35+5.42%38
RMDResMed Inc.
$240.51+5.91%91
DXCMDexCom, Inc.
$88.47+6.63%85

Held by ETFs

SYK is in 318 US ETFs. The largest of them, with SYK's weight in each:

Spot a number that looks wrong? Check it in SYK's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SYK

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.